Activating mutations of IL7R (5p13), JAK1 (1p32), JAK3 (19p13), and/or STAT5B (17q21) are present in 20–30% of T-ALL cases, with a higher frequency in ETP-ALL patients (33, 74). The gene discussed is IL7R; the disease is acute lymphoblastic leukemia.